A STUDY OF SUPERIOR VENA CAVA OBSTRUCTION SYNDROME
نویسندگان
چکیده
منابع مشابه
Superior vena cava syndrome.
Approximately 15,000 cases of superior vena cava (SVC) obstruction are diagnosed in the United States annually. Malignancies (primarily lung cancer) are the underlying cause of 80-85% of cases, leaving 15-20% caused by various benign conditions, including sclerosing mediastinitis (the diagnosis in our case). Thrombolytic therapy and major advances in vascular techniques in recent years have imp...
متن کاملSuperior Vena Cava Syndrome
1.1 Anatomy The superior vena cava (SVC) originates in the chest, behind the first right sternocostal articulation, from the confluence of two main collector vessels: the right and left brachiocephalic veins which receive the ipsilateral internal jugular and subclavian veins. It is located in the anterior mediastinum, on the right side. The internal jugular vein collects the blood from head and...
متن کامل[Superior vena cava syndrome].
Superior vena cava syndrome is a common complication of malignancy. The epidemiology, presentation, and diagnostic evaluation of patients presenting with the syndrome are reviewed. Management options including chemotherapy and radiation therapy and the role of endovascular stents are discussed along with the evidence for each of the therapeutic options.
متن کاملVascular spinal cord obstruction associated with superior vena cava syndrome
RATIONALE Superior vena cava syndrome (SVCS) is the obstruction of blood flow through the SVC, causing complete or partial blockade of the collateral circulation of returning venous blood. SVCS is frequently presented with facial, neck, trunk, and upper limbs swelling and so on. However, to the best of our knowledge, the obstruction of the venous return in the spinal veins is rarely a manifesta...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical Journal Armed Forces India
سال: 1997
ISSN: 0377-1237
DOI: 10.1016/s0377-1237(17)30674-3